Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
Year of publication: |
2011
|
---|---|
Authors: | Mitchell, Paul ; Annemans, Lieven ; White, Richard ; Gallagher, Meghan ; Thomas, Simu |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 2, p. 107-131
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Age-related-macular-degeneration | treatment | Bevacizumab | therapeutic use | Cost-effectiveness | Pegaptanib | Photochemotherapy | Ranibizumab | Verteporfin |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review
Shih, Ya-Chen T., (2011)
-
Wilson, Edward C.F., (2010)
-
Advances in Cancer Therapeutics and Patient Access to New Drugs
Dranitsaris, George, (2011)
- More ...
-
Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
Mitchell, Paul, (2011)
-
Hill, Jerrold, (2006)
-
Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs
Darkow, Theodore, (2007)
- More ...